2785 Protocol for a feasibility randomised controlled trial of the OUTDOOR mobility intervention for older adults after hip fracture

• DOI: 10.1093/ageing/afae277.132
• Publication Date: 2025-01-30T15:31:47Z
• Authors: KJ Sheehan; D Bastas; A Lyczmanenko; S Guerra; S Creanor; C Hulme; S Lamb; FC Martin; C Sackley; T Smith; P Bell; M Hillsdon; S Pope; H Cook; E Godfrey
• Keywords: Hip Fracture

Abstract Introduction A high proportion of patients do not regain outdoor mobility after hip-fracture. Rehabilitation explicitly targeting is needed to enable older adults resume activities that they value most. The aim this study determine the feasibility a randomised, controlled trial intended assess clinical and cost-effectiveness an intervention enabling recovery post hip-fracture (the OUTDOOR intervention). Method multi-centre, parallel group, controlled, trial. Adults 60 years older, admitted hospital planned discharge home; with self-reported three-months pre-fracture, surgically treated for hip fracture, who are able consent participate, eligible. Individuals requiring two or more people support upon excluded. Screening (or contact) will take place in hospital. Baseline assessment randomisation follow discharge. Participants receive usual care (physiotherapy, occupational therapy), plus intervention. includes goal-orientated programme, therapist-led motivational dialogue supported by past-patient led videos sharing experiences; transition independent recovery. Therapists delivering training interviewing, behaviour change techniques. Patient reported outcome measures—health-related quality life, daily activities, pain, community mobility, falls related self-efficacy, resource use, readmission; be collected at baseline, 6-weeks, 12-weeks, 6-months (if enrolled early trial) post-randomisation. Exercise adherence acceptability collected. Subset 20 participants accelerometery data collection 10 days each time point. Trial received approval from East England—Essex Research Ethics Committee (REF: 23/EE/0246) Health Authority. Findings disseminated patients, public, health professionals researchers through publications, presentations, social media. registered ISRCTN16147125.